HNN3.0
Register
Register
Register

Bogazici University Center for Targeted Therapy Technologies

R&D Institution

ct3.bogazici.edu.tr/İstanbul, Türkiye

About

Boğaziçi CT3 (Center for Targeted Therapy Technologies of Boğaziçi University) is a prominent research center within Boğaziçi University (Istanbul, Türkiye), focusing on innovative and high-impact research in life sciences and technologies.

The center leverages Boğaziçi University's strengths in natural and applied sciences to drive technological advancements, not only in the rapidly advancing fields of medical biotechnology, but also within a novel set of “smart” in vivo biomedical devices.

It fosters active collaborations between academia, industry, and healthcare sector with its recently updated sharp focus on targeted therapy technologies.

Established within one of nation’s leading universities, Boğaziçi University’s CT3 supports multidisciplinary research and is the national trailblazer when it comes to successful technology transfer, academic spin-off and commercialization activities from biomedical and biotechnological academic innovations.

Representatives

Head of Project & IP Management

Bogazici University Center for Targeted Therapy Technologies

Marketplace (1)

  • Project cooperation

    CUTIVAX

    A Subcutaneous & Tumor Resection Cavity Implantable Immunotherapy Platform

    • Consortium/Coordinator seeks Partners
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    Author

    Head of Project & IP Management at Bogazici University Center for Targeted Therapy Technologies

    İstanbul, Türkiye